Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

BioMarin Pharmaceutical Sees FY23 EPS $0.78-$1.03 Vs $0.95 Est.; FY23 $2.375M-$2.5M Vs $2.46B Est.

By Happy Mohamed
April 26, 4:08 PM
2023 Full-Year Financial Guidance (in millions, except % and EPS amounts) (Updated) Item   2023 Guidance   Updated April 26,

BMRN

Read More
1 minute read
  • Guidance
  • News

Mattel Reiterates FY23 Guidance

By Benzinga Newsdesk
April 26, 4:08 PM
2023 Guidance Mattel's full year 2023 guidance remains: (in millions,    

MAT

Read More
2 minute read
  • Cannabis
  • General
  • Guidance
  • Health Care
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Top Stories

This Firm Bets On Non-Hallucinogenic Psychedelics, Files Claims For International IP Protection

By Lara Goldstein
April 26, 2:52 PM
Numerous biopharma companies are working on enhancing first-generation or “classical” psychedelics. They're tuning down the side effects, and protecting their findings along the way.

MSSTF

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Movers
  • News

Why Integra LifeSciences (IART) Stock Is Plunging Today

By Vandana Singh
April 26, 2:27 PM
Integra LifeSciences Holdings Corp (NASDAQ: IART) reported 

IART

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • News

Rogers Communication Clocks 6% Revenue Spike In Q1 Backed By Postpaid Subscriptions

By Nabaparna Bhattacharya
April 26, 1:24 PM
Rogers Communication, Inc (NYSE:RCI) reported first-quarter FY23 revenue growth of 6% year-on-year to CA$3.84 billion. Total service revenue grew 4% Y/Y…

RCI

Read More
2 minute read
  • Dividends
  • Earnings
  • Earnings Beats
  • Guidance
  • News

Otis Worldwide Reports Q1 Results Above Consensus

By Akanksha Bakshi
April 26, 12:22 PM
Otis Worldwide Corp (NYSE:OTIS) reported a first-quarter FY23 sales decline of 2% year-over-year to $3.35 billion, +3.6% on an…

OTIS

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • News

Ryder Q1 Earnings Miss Estimates; Warns On Reduced Earnings In 2023 On Weak Freight Conditions

By Shivani Kumaresan
April 26, 11:59 AM
Ryder System Inc (NYSE:R) reported first-quarter FY23 sales growth of 3% year-on-year to $2.95 billion, missing the consensus of $2.99 billion.…

R

Read More
1 minute read
  • Earnings
  • Guidance
  • News
  • Tech

Amphenol Clocks Weak Revenue Growth In Q1, FY23 Outlook Lags Street View

By Anusuya Lahiri
April 26, 11:46 AM
Amphenol Corp (NYSE:APH) reported first-quarter FY23 sales growth of 1% year-on-year to $2.97 billion, beating the consensus of $2.90 billion.…

APH

Read More
1 minute read
  • Earnings
  • Guidance
  • News

ADP Q1 Highlights: Beats Expectations, Raises FY23 EPS Outlook

By Anusuya Lahiri
April 26, 11:28 AM
Automatic Data Processing, Inc (NASDAQ: ADP) reported third-quarter FY23 revenue growth of 10% year-on-year to $4.93 billion, beating the consensus of $4.88 billion.

ADP

Read More
1 minute read
  • Earnings
  • Guidance
  • News

American Tower Beats Street Topline View, Organic Tenant Billings See Growth

By Anusuya Lahiri
April 26, 11:23 AM
American Tower Corp (NYSE: AMT) reported first-quarter FY23 revenue growth of 4% year-on-year to $2.77 billion, beating the consensus estimate of…

AMT

Posts pagination

Previous 1 … 444 445 446 … 637 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service